Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults.
Phase of Trial: Phase II
Latest Information Update: 05 Nov 2010
At a glance
- Drugs Hepatitis B vaccine; Hepatitis B vaccine recombinant; V 270
- Indications Hepatitis B
- Focus Adverse reactions; Pharmacodynamics
- 05 Nov 2010 New trial record.